Randomized Controlled Trial of the Comparison of Uniport VATS and Non- Uniport VATS for Lung Cancer

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Video-assisted thoracoscopic surgery (VATS) has been widely used for non-small cell lung cancer (NSCLC) for nearly two decades. Usually, it was applied through three ports with at least one drainage after surgery, which often lead to acute chest pain. Therefore, fewer, smaller ports, and wider intercostal space for surgery has been required. Uniport VATS became a feasible option with the development of surgical techniques and instruments, with potentially less postoperative pain and shorter hospital stays. However, there may be some complications, or with a longer time of operation, even more difficult in lymph nodes resection during learning curve. In our study, a Randomized Controlled Trial was designed to study the operation time, perioperative blood loss, conversion rate, duration of postoperative drainage, length of hospital stay, visual analogue score of postoperative pain, complications, and survival.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 25
Maximum Age: 80
Healthy Volunteers: f
View:

• patients with cT1-3N0-1M0 NSCLC; good cardiopulmonary function; prepared to undergo radical resection;

Locations
Other Locations
China
The Second Hospital of Shandong University
RECRUITING
Jinan
Contact Information
Primary
Yunpeng Zhao, Doctor
zyp_baggio@163.com
+8618766188692
Time Frame
Start Date: 2019-12-25
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 300
Treatments
Experimental: single port group
Uniport video-assisted thoracoscopic surgery for NSCLC
Active_comparator: two ports group
video-assisted thoracoscopic surgery for NSCLC using two ports
Active_comparator: three ports group
video-assisted thoracoscopic surgery for NSCLC using three ports
Sponsors
Leads: The Second Hospital of Shandong University

This content was sourced from clinicaltrials.gov